Cargando…

Population Pharmacokinetics of Colistin Methanesulfonate Sodium and Colistin in Critically Ill Patients: A Systematic Review

Understanding the pharmacokinetics parameter of colistin methanesulfonate sodium (CMS) and colistin is needed to optimize the dosage regimen in critically ill patients. However, there is a scarcity of pharmacokinetics parameters in this population. This review provides a comprehensive understanding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zabidi, Mohd Shafie, Abu Bakar, Ruzilawati, Musa, Nurfadhlina, Mustafa, Suzana, Wan Yusuf, Wan Nazirah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472798/ https://www.ncbi.nlm.nih.gov/pubmed/34577603 http://dx.doi.org/10.3390/ph14090903

Ejemplares similares

The risk factors of colistin methanesulfonate associated nephrotoxicity
por: Tigen, Elif Tükenmez, et al.
Publicado: (2016)

Pharmacokinetics and Pharmacodynamics of Colistin Methanesulfonate in Healthy Chinese Subjects after Multi-Dose Regimen
por: Fan, Yaxin, et al.
Publicado: (2022)

Neurotoxicity associated with colistin methanesulfonate treatment is enhanced by concomitant sevoflurane inhalation
por: Gotoda, Mai, et al.
Publicado: (2022)

Pharmacokinetics of inhaled colistin in critically ill patients with ventilator-associated tracheobronchitis
por: Athanassa, Z, et al.
Publicado: (2012)

Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy
por: Yu, Xu-ben, et al.
Publicado: (2022)

Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients
por: Xie, Yue-liang, et al.
Publicado: (2022)

Commentary: Population pharmacokinetics of colistin sulfate in critically ill patients: Exposure and clinical efficacy
por: Chen, Huadong, et al.
Publicado: (2022)

Management of Meningitis Caused by Multi Drug-Resistant Acinetobacter Baumannii: Clinical, Microbiological and Pharmacokinetic Results in a Patient Treated with Colistin Methanesulfonate
por: Schiaroli, Elisabetta, et al.
Publicado: (2015)

Synergistic Effects of Capric Acid and Colistin against Colistin-Susceptible and Colistin-Resistant Enterobacterales
por: Liu, Yi-Yun, et al.
Publicado: (2022)

Characterization of colistin tissue pharmacokinetics by microdialysis
por: Matzneller, Peter, et al.
Publicado: (2012)

Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study
por: Rocco, Monica, et al.
Publicado: (2013)

Renal and neurological side effects of colistin in critically ill patients
por: Spapen, Herbert, et al.
Publicado: (2011)

Comparison of colistin-induced nephrotoxicity between two different formulations of colistin in critically ill patients: a retrospective cohort study
por: Feng, Jia-Yih, et al.
Publicado: (2021)

Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010)

Inhaled colistin for the treatment of ventilator-associated tracheobronchitis in critically ill patients
por: Athanassa, Z, et al.
Publicado: (2011)

Differences in Colistin Administration and Bacterial and Treatment Outcomes in Critically Ill Patients
por: Jung, Sunmi, et al.
Publicado: (2019)

Efficacies of Colistin–Carbapenem versus Colistin–Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study
por: Wang, Sheng-Huei, et al.
Publicado: (2021)

Genomic and Transcriptomic Analysis of Colistin-Susceptible and Colistin-Resistant Isolates Identify Two-Component System EvgS/EvgA Associated with Colistin Resistance in Escherichia coli
por: Wan, Fen, et al.
Publicado: (2021)

Intra-Pleural Colistin Methanesulfonate Therapy for Pleural Infection caused by Carbapenem-Resistant Acinetobacter Baumannii: A Successful Case Report
por: Rana, Muhammad Asim, et al.
Publicado: (2014)

Azithromycin possesses biofilm–inhibitory activity and potentiates non-bactericidal colistin methanesulfonate (CMS) and polymyxin B against Klebsiella pneumonia
por: Moshynets, Olena V., et al.
Publicado: (2022)

Transition of colistin dependence into colistin resistance in Acinetobacter baumannii
por: Lee, Ji-Young, et al.
Publicado: (2017)

Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients
por: Michalopoulos, Argyris S, et al.
Publicado: (2011)

Intravenous fosfomycin therapy in critically ill patients infected with colistin-resistant enterobacteriacae
por: Mukherjee, DN, et al.
Publicado: (2015)

Critical-Illness: Combined Effects of Colistin and Vasoactive Drugs: A Pilot Study
por: Stamatiou, Rodopi, et al.
Publicado: (2023)

Management with colistin
por: Singh, Harkirat
Publicado: (2010)

Colistin Susceptibility Testing Using the MicroScan® Colistin Well
por: Lutgring, Joseph, et al.
Publicado: (2017)

Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates
por: Kon, Hadas, et al.
Publicado: (2021)

Synergistic Activity of Niclosamide in Combination With Colistin Against Colistin-Susceptible and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
por: Ayerbe-Algaba, Rafael, et al.
Publicado: (2018)

An overview of colistin resistance, mobilized colistin resistance genes dissemination, global responses, and the alternatives to colistin: A review
por: Gharaibeh, Mohammad H., et al.
Publicado: (2019)

High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia
por: Omrani, Ali S, et al.
Publicado: (2015)

Colistin Dosing Regimens against Pseudomonas aeruginosa in Critically Ill Patients: An Application of Monte Carlo Simulation
por: Nguyen, Van Thi Khanh, et al.
Publicado: (2021)

Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria
por: Witherell, Kaitlin S., et al.
Publicado: (2020)

A Comparison of Colistin versus Colistin Plus Meropenem for the Treatment of Carbapenem-Resistant Acinetobacter baumannii in Critically Ill Patients: A Propensity Score-Matched Analysis
por: Katip, Wasan, et al.
Publicado: (2020)

Convulsions in a critically ill patient on hemodialysis: Possible role of low dose colistin
por: Sodhi, Kanwalpreet, et al.
Publicado: (2014)

Colistin dosing for treatment of multidrug-resistant Pseudomonas in critically ill patients - please, be adequate!
por: Honoré, Patrick M, et al.
Publicado: (2014)

Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients
por: Papathanakos, Georgios, et al.
Publicado: (2020)

Extensive Therapeutic Drug Monitoring of Colistin in Critically Ill Patients Reveals Undetected Risks
por: Ehrentraut, Stefan Felix, et al.
Publicado: (2020)

Ursolic acid inhibits colistin efflux and curtails colistin resistant Enterobacteriaceae
por: Sundaramoorthy, Niranjana Sri, et al.
Publicado: (2019)

An Unusual Case of the Successful Treatment of Carbapenem-resistant Ventriculitis with Intravenous Colistin
por: Abu Bakar, Azizi, et al.
Publicado: (2020)

High-Dose Nebulized Colistin Methanesulfonate and the Role in Hospital-Acquired Pneumonia Caused by Gram-Negative Bacteria with Difficult-to-Treat Resistance: A Review
por: Karaiskos, Ilias, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cf4lm8eouecan3ir7aaa887c7a